A new study reports that the dopamine agonist pramipexole appears to have direct antidepressant effects in Parkinson’s disease patients with comorbid depression (Bxarone et al. Lancet Neurol 2010; 9: 573-580).
It takes 30 seconds or login using your email address
Please enter the email address that you registered the newsletter with
